Summit Financial’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
GIA
BFM
AF
PC
AC
AIM
Summit Financial's DRTS Position: Q2 2026 in Review
Summit Financial reduced its Alpha Tau Medical (DRTS) stake by 35% in Q2 2026, selling an estimated $94.7K and leaving 19,570 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.
Summit Financial first reported a position in DRTS in Q3 2025 and has held it in 4 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.
- Summit Financial held 19,570 shares of Alpha Tau Medical worth $246K as of Q2 2026.
- Summit Financial sold 10,430 Alpha Tau Medical shares in Q2 2026, an estimated $94.7K.
- Alpha Tau Medical made up ﹤0.01% of Summit Financial's portfolio in Q2 2026, its #1423 holding.
- Summit Financial first reported a position in Alpha Tau Medical in Q3 2025 and has held it in 4 quarters since.
- 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.
Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.